Sherene Min

5.6k citations
46 papers · 3.3k · 3 hit papers · h-index 24

Impact in

  • Virology top 0.2%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • HIV/AIDS Research and Interventions

Papers in

    • HIV/AIDS drug development and treatment 41
    • HIV/AIDS Research and Interventions 17
    • HIV Research and Treatment 33

Sherene Min

42 papers receiving 3.3k citations

Sherene Min's Hit Papers

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study 2014 · 350 citations
3500+4+8Years since publication100200300400500

Peers

Sherene Min
Comparison fields: 5 of 93
  • Virology 2.3k
  • Infectious Diseases 3.1k
  • Emergency Medicine 654
  • Hepatology 209
  • Epidemiology 556
Replace Daniel Podzamczer with:
Daniel Podzamczer Spain
Thomas N. Kakuda United States
Brian Wynne United States
Ivy Song United States
Pieter L. Meenhorst Netherlands
Jennifer J. Kiser United States
Joseph M. Custodio United States
Laura Waters United Kingdom
Sonia Rodríguez‐Nóvoa Spain
Brian P. Kearney United States
Sherene Min relative to Daniel Podzamczer Spain Daniel Podzamczer's profile →
Citations per field
00.5×1.5×
Daniel Podzamczer · 1×
Citations per year

Countries citing papers authored by Sherene Min

Since Specialization
Citations

This map shows the geographic impact of Sherene Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherene Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherene Min more than expected).

Fields of papers citing papers by Sherene Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherene Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherene Min. The network helps show where Sherene Min may publish in the future.

Co-authors

The 25 scholars most cited alongside Sherene Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sherene Min Line = papers co-authored together Sherene Min links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
Hit paper breakdown →
2013593
2
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study
Hit paper breakdown →
2013404
3
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study
Hit paper breakdown →
2014350
4 2013269
5 2011226
6 2009191
7 2011171
8 2013131
9 2013113
10 201392
11 200471
12 201161
13 201558
14 201155
15 201052
16 200943
17 200443
18 201540
19 202235
20 201434

About Sherene Min

Sherene Min is a scholar working on Infectious Diseases, Virology, Epidemiology, Pediatrics, Perinatology and Child Health and Molecular Biology, having authored 46 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (41 papers), HIV Research and Treatment (33 papers), HIV/AIDS Research and Interventions (17 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Biochemical and Molecular Research (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), HIV-related health complications and treatments (4 papers) and Hepatitis C virus research (4 papers). The work is most often cited by research in Virology (2.3k citations), Infectious Diseases (3.1k citations), Emergency Medicine (654 citations), Hepatology (209 citations) and Epidemiology (556 citations). Sherene Min has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Ivy Song, Yu Lou, Tamio Fujiwara, Stephen C. Piscitelli, Clare Brennan, Julie Borland, Franco Maggiolo, François Raffi, Shuguang Chen and Brian Wynne. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS, British Journal of Clinical Pharmacology and The Lancet Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact